Dose-ranging study of indole-3-carbinol for breast cancer prevention

Journal of Cellular Biochemistry

Volumn 67, Issue SUPPL. 28/29, 1997, Pages 111-116

  Wong, George Y C ^a   Bradlow, Leon ^a   Sepkovic, Daniel ^a   Mehl, Stephanie ^a   Mailman, Joshua ^a   Osborne, Michael P ^a  

^a STRANG CANCER PREVENTION CENTER   (United States)

Author keywords

Chemoprevention; Estrogen metabolites; Surrogate endpoint biomarker

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRONE; 3 INDOLEMETHANOL; BIOLOGICAL MARKER; ESTROGEN; PLACEBO; INDOLE DERIVATIVE; INDOLE-3-CARBINOL;

ADULT; ARTICLE; BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; TREATMENT OUTCOME; BREAST TUMOR; DIET;

ADULT; BREAST NEOPLASMS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOLES; PLACEBOS; REGRESSION ANALYSIS;

EID: 0031401942     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1997)28/29+<111::AID-JCB12>3.0.CO;2-K     Document Type: Article

References (13)

1. Wattenberg LW, Loub WD (1978): Inhibition of polycyclic aromatic hydrocarbon induced neoplasia by naturally occurring indoles. Cancer Res 38:1410-1413.
2. Telang NT, Suto A, Wong GYC, Osborne MP, Bradlow HL (1992): Induction by estrogen metabolite 16α-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. JNCI 84:634-636.
3. Suto A, Bradlow HL, Wong GYC, Osborne MP, Telang NT (1993): Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Res Treat 27:193-202.
4. Bradlow HL, Sepkovic DW, Klug T, Osborne MP (1998): Application of an improved Elisa assay to the analysis of urinary estrogen metabolites. Steroids (in press).
5. Bradlow HL, Michnovicz JJ, Telang NT, Osborne MP (1991): Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12:1571-1574.
6. Grubbs C, Steele VE, Casebolt T, Juliane MM, Eto I, Whitaker LM, Dragnec KH, Kelloff GJ, Lubet RL (1995): Chemoprevention of chemically induced mammary carcinogenesis by indole-3-carbinol. Anti-Cancer Res 15: 709-716.
7. Osborne MP, Karmali RA, Hershcopf RJ, Bradlow HL, Kourides IA, Williams WR, Rosen PP, Fishman J (1988): Omega-3 fatty acids: Modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Invest 6:629-631.
8. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J (1985): Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci USA 82:6295-6299.
9. Taioli E, Bradlow HL, Garbers SV, Sepkovic DW, Osborne MP, Trachman J, Ganguly S, Garte SJ (1998): Cyp1A1 genotype, estradiol metabolism and breast cancer in African-Americans. Cancer Prev Detect (in press).
10. Niwa T, Swaneck G, Bradlow HL (1994): Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds. Steroids 58:523-527.
11. Tiwari RK, Li Guo, Bradlow HL, Telang NT, Osborne MP (1994): Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent. JNCI 86:126-131.
12. Michnovicz JJ, Bradlow HL (1990): Induction of estradiol metabolism by dietary indole-3-carbinol in humans. JNCI 82:947-949.
13. Bradlow HL, Michnovicz JJ, Halper M, Miller DG, Wong GYC, Osborne MP (1994): Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prev 3:591-595.